SCHEMBL32690687

SCHEMBL32690687

COC(=O)/C=C/c1ccc2[nH]c(-c3ccccc3OC)c(O)c(=O)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.48
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ MAPT P10636 4/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ HPGD P15428 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ CCNB2 O95067 1/20 0.43
▸ CDK1 P06493 1/20 0.43
▸ CCNB1 P14635 1/20 0.43
▸ GSK3B P49841 1/20 0.43
▸ CDK5 Q00535 1/20 0.43
▸ CDK5R1 Q15078 1/20 0.43
▸ CCNB3 Q8WWL7 1/20 0.43
▸ FDPS P14324 1/20 0.43
▸ APP P05067 2/20 0.43
▸ TTR P02766 1/20 0.43
▸ JAK2 O60674 1/20 0.42
▸ GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32690654 0.90 HDAC1 (0.47) MAPTHDAC3HDAC1HDAC6MMP1
SCHEMBL32690804 0.89 CCNB2 (0.44) EPHX2MAPTKDM4EALDH1A1HPGD
SCHEMBL32690795 0.88 CCNB2 (0.45) EPHX2MAPTKDM4EALDH1A1HPGD
SCHEMBL32690662 0.85 CCNB2 (0.49) EPHX2MAPTKDM4EALDH1A1HPGD
SCHEMBL32690696 0.78 GSK3B (0.53) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL23791549 0.78 KDM4E (0.51) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL32690720 0.77 CCNB2 (0.45) EPHX2MAPTKDM4EALDH1A1CCNB2
SCHEMBL32690705 0.76 HDAC1 (0.48) APPHDAC3HDAC1HDAC6
SCHEMBL12408499 0.76 KIF11 (0.55) EPHX2MEN1KMT2AMAPTKDM4E
SCHEMBL30440640 0.76 KIF11 (0.55) EPHX2MEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition NOX1, NOX4, CYBB EPHX2 2000/4885MEN1 4795/4885KMT2A 463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback